Gulf Pharmaceutical Industries P.S.C. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was AED 366 million compared to AED 415.8 million a year ago. Net loss was AED 39.3 million compared to net income of AED 4.1 million a year ago. Basic loss per share was AED 0.034 compared to basic earnings per share of AED 0.004 a year ago.
For the nine months, sales was AED 1,225.4 million compared to AED 1,254.3 million a year ago. Net loss was AED 83.4 million compared to net income of AED 10.4 million a year ago. Basic loss per share was AED 0.072 compared to basic earnings per share of AED 0.009 a year ago.